SLU-PP-332 Dosing & Reconstitution Guide
Dosing Protocol
Route: Subcutaneous injection (EXPERIMENTAL — extrapolated from murine oral dosing) Frequency: Twice daily Dose Range: 1250-2500 mcg daily (SPECULATIVE — NO HUMAN DATA) Cycle Length: Unknown — no human protocol exists Timing: Morning and evening (split dosing)
Titration Schedule
Weeks 1-2: 625 mcg twice daily (1250 mcg/day) Weeks 3+: 1250 mcg twice daily (2500 mcg/day)
Storage
Lyophilized: Freeze at -20 °C, protect from light and moisture Reconstituted: Refrigerate 2-8 °C, use within 7 days
Injection Sites
Abdomen
Safety & Contraindications
Safety: CRITICAL: No human safety data exists All safety information derived from mouse studies only Mice tolerated twice-daily dosing without reported toxicity
Contraindications: No human use is recommended — purely experimental; Unknown effects on fertility and reproduction; Unknown hepatotoxicity potential